Development of a new selective plating medium for Rhodococcus equi.
A new selective plating medium for Rhodococcus equi containing ceftazidime (20 mg/l) and novobiocin (25 mg/l) on a Mueller-Hinton agar basis is described. It proved to be less inhibitory for R. equi than selective plating media devised earlier and grew only very few other nocardioform bacteria.
von Graevenitz
A
A
Department of Medical Microbiology, University of Zurich, Switzerland.
Pünter-Streit
V
V
D000193:Actinomycetales Infections / Q000382:microbiology; D002442:Ceftazidime / Q000494:pharmacology; D003470:Culture Media; D005243:Feces / Q000382:microbiology; D006094:Gram-Positive Bacteria / Q000187:drug effects / Q000502:physiology; D006679:HIV Seropositivity / Q000382:microbiology; D006801:Humans; D008828:Microbiological Techniques; D009675:Novobiocin / Q000494:pharmacology; D016929:Rhodococcus equi / Q000302:isolation & purification / Q000502:physiology*; D013183:Sputum / Q000382:microbiology
D003470:Culture Media; D009675:Novobiocin; D002442:Ceftazidime